Article Details

Pfizer's Novel COVID-19 Oral Treatment Demonstrates In Vitro Efficacy Against Omicron Variant

Retrieved on: 2022-01-20 17:21:38

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's Novel COVID-19 Oral Treatment Demonstrates In Vitro Efficacy Against Omicron Variant. View article details on hiswai:

Excerpt

These findings provide confirmation to Pfizer's findings that nirmatrelvir is the only orally administrable, authorized/approved compound which, to ...

Article found on: www.hospimedica.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up